Abstract:Benign epilepsy with centrotemporal spikes (BECTS) is the most common epilepsy syndrome and the aetiology is unclear, but recent epidemiological research has suggested that it is a neurological disorder with a strong genetic basis.1 We recruited a pair of twins, only one of which exhibited BECTS. The proband was an 11-year-old girl diagnosed with BECTS. Her first reported symptoms were seizures at the age of 9 years and sudden loss of consciousness followed by tonic–clonic movements of the extremities lasting 10 min. Electroencephalogram showed bilateral centrotemporal spikes with electrical status epilepticus during sleep. Whole-exome sequencing was performed on the proband, her normal twin sister and their parents. A de novo heterozygous variant in KCNT1, p.R1061Q, was found, which was further confirmed by Sanger sequencing. The KCNT1 gene belongs to a large family of genes encoding potassium channels. The missense variant p.R1061Q leads to a change from arginine to glutamic acid at residue 1061, and was predicted to damage the protein function of KCNT1. The analysis of the twin sisters and the family-based whole-exome sequencing helped us to quickly narrow down the list of candidate variants associated with BECTS. KCNT1 mutation can lead to different forms of epilepsy,2 which may be related to the location of the mutation. We found that the mutation was located at the 1061st amino acid near the C-terminus, which has not previously been reported in epilepsy patients. However, the 1106th amino acid, or c.3317G>A, p.Arg1106Gln, was reported to be associated with Brugada syndrome, a cardiac disorder comorbidity for epilepsy.3 Moreover, Tiron et al. found that long QT syndrome, a congenital disorder characterised by prolongation of the QT interval on electrocardiograms, coexists with epilepsy, which is associated with mutation in KCNQ1, which like KCNT1 belongs to the potassium ion channel group of genes.2 Understanding the patient's genetic background should be beneficial for precisely choosing the most appropriate treatment. Studies have shown the promise of quinidine as a targeted intervention for patients with KCNT mutations.4 Further clinical trials of quinidine treatment in patients with KCNT1 mutations in BECTS are also necessary, and in-depth functional studies will be necessary to determine the pathogenic role of KNCT1 in BECTS. This project was supported by the National Natural Science Foundation of China (programme nos. 81500974, 81701351, 81471329 and 81720108018) and Shenzhen Science Technology and Innovation Commission (programme nos. JCYJ20160429174706491 and JCYJ20170413093358429).

Whole‐Exome Sequencing Revealing De Novo Heterozygous Variant OF KCNT1 in a Twin Discordant for Benign Epilepsy with Centrotemporal Spikes

A Novel Mutation in KCNQ2 Gene Causes Benign Familial Neonatal Convulsions in a Chinese Family

Autosomal Dominant Sleep-Related Hypermotor Epilepsy Associated with a Novel Mutation of KCNT1.

A novel KCNT1 mutation in a Chinese family with severe autosomal-dominant nocturnal frontal lobe epilepsy

A novel loss-of-function KCNB1 gene variant in a twin with global developmental delay and seizures

KCNH2 variants in a family with epilepsy and long QT syndrome: A case report and literature review

Infantile seizures and other epileptic phenotypes in a Chinese family with a missense mutation of KCNQ2

Germline De Novo Variants in CSNK2B in Chinese Patients with Epilepsy.

Novel KCNQ2 Missense Variant Expands the Genotype Spectrum of DEE7.

The Epilepsy of Infancy With Migrating Focal Seizures: Identification of de novo Mutations of the KCNT2 Gene That Exert Inhibitory Effects on the Corresponding Heteromeric KNa1.1/KNa1.2 Potassium Channel

Clinical Features of KCNB1 Gene Variation Related Developmental and Epileptic Encephalopathy

Phenotypic expansion of <i>KCNH1</i>-associated disorders to include isolated epilepsy and its associations with genotypes and molecular sub-regional locations

KCNT1-related epilepsy: An international multicenter cohort of 27 pediatric cases

Identification of Susceptibility Variants to BECTS in Chinese Han Population

Clinical Study of 30 Novel KCNQ2 Variants/Deletions in KCNQ2-Related Disorders.

H258R mutation in KCNAB3 gene in a family with genetic epilepsy and febrile seizures plus

Identification of a novel KCNT2 variant in a family with developmental and epileptic encephalopathies: a case report and literature review

Clinical and genetic analysis of 23 Chinese children with epilepsy associated with KCNQ2 gene mutations

Epilepsies Associated With Kcnq2 Complicated By Supraventricular Tachycardia Due To A De Novo Mutation In Kcnq2

Novel Mutations and Phenotypes of Epilepsy-Associated Genes in Epileptic Encephalopathies.

Clinical and genetic analysis of Chinese patients with KCNQ2 mutation－induced neonatal/infantile epileptic disorders